Navigation Links
Ranbaxy in Fray to Buy Merck's Generic Drugs Unit

Davos: After six global acquisitions last year, India's Ranbaxy Laboratories has entered the market again to acquire the generic drugs business of German// pharmaceuticals major Merck in a deal estimated at over $5 billion.

‘We are in talks with private equity funds to finance the deal,’ Ranbaxy's chief executive Malvinder Singh said on the margins of the annual meeting of the World Economic Forum (WEF) here. ‘We are being hounded by them for the takeover.’

According to Singh, the due diligence for the acquisition was expected to start next month. He, however, declined to give any financial details.

‘Merck makes sense for us since it would result in a major gain for us in the global generics business and a strategic fit for our activities,’ Singh said, adding: ‘I have been talking to some private equity funds even here.’

According to pharmaceutical industry sources, Merck's generics business records annual revenues around $2.5 billion and has the potential to more than triple Ranbaxy's turnover to around $3.75 billion after the acquisition.

The merger of Ranbaxy and Merck's generics business could result in a stable of 100 products in the US alone for drugs in diabetics, neurology, cardiovascular and neurology, among other areas.

The generics unit of the German major is the largest supplier in markets like Australia, France and Scandinavia.

Ranbaxy had acquired four companies in Europe last year, including Terapia of Romania, for $324-million. The company has approval from shareholders to sell bonds and shares worth $1.5 billion.

Source-IANSSRM
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... 2017 , ... Altec Products, Inc., a leader in enterprise document ... technology conference in San Diego, CA. , At nVerge 2017, Altec will be ... and enhance their Sage ERP solutions by providing improved visibility and control to the ...
(Date:5/24/2017)... ... , ... Patients who want to receive cosmetic dentistry procedures such as Invisalign® ... for a consultation, with or without a referral. Dr. Bedich enjoys improving the appearance ... , Dr. Bedich offers a variety of cosmetic dentistry services at his practice that ...
(Date:5/24/2017)... Lake Orion, Michigan (PRWEB) , ... ... ... is a disease affecting the female reproductive tract in which the endometrial ... the pelvic structures causing inflammation and pain. Patients experiencing painful intercourse, painful ...
(Date:5/24/2017)... ... May 24, 2017 , ... Adelberg-Montalvan Pediatric ... options for its patients on Long Island, New York. , Holistic dentistry ... and is one of the biggest trends in dentistry today. , Dentist ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Technique, technique, ... back injury when either lifting weights for strength training and exercise or simply lifting ... Center . , “Body position is everything,” Dr. Chang says. “Improper technique in lifting ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology: